40%–60% of medications on the global market originate from plant extracts
The medical use of cannabis in oncology represents less than 3% of all prescriptions in the United States, compared with 8%–23% in the Netherlands.11.
The legalization of medical cannabis production in Canada will also lead to advanced scientific research to identify the most active therapeutic molecules as well as their ideal administration routes.
Reference 1: The Intersection between cannabis and cancer in the United States. D.W. Bowles et al, Critical Reviews in Oncology/Hematology 83 (2012) 1-10
The positivism of the medical world for innovative cannabis medications.
Despite conclusive medical literature, the proven therapeutic benefits of cannabinoids continue to be greatly underestimated and underused among the general public and in the medical community. It is unfortunate, even today, that pharmacological derivatives of cannabis sometimes receive negative press by being misleadingly associated with recreational use and its potential for abuse. Medical et recreational use of cannabis are two completely different issues.
CanNorth Medic is a corporation owned by Quebec interests. The company has applied to Health Canada to become an authorized cannabis producer for the production, processing and marketing of cannabis for medical use.
Varennes, Qc, Canada